Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Wave Life Sci Ord Sh
(NQ:
WVE
)
14.35
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
14.35
Bid (Size)
7.710 (1)
Ask (Size)
15.48 (1)
Prev. Close
14.35
Today's Range
14.35 - 14.35
52wk Range
3.500 - 16.73
Shares Outstanding
98,983,261
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Wave Life Sciences to Present at Jefferies London Healthcare Conference
November 15, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Performance
YTD
+168.73%
+168.73%
1 Month
-3.24%
-3.24%
3 Month
+159.96%
+159.96%
6 Month
+135.63%
+135.63%
1 Year
+165.74%
+165.74%
More News
Read More
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
What's Next: WAVE Life Sciences's Earnings Preview
November 11, 2024
Via
Benzinga
Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
November 04, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
October 30, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
1 Brand-New Big Reason to Buy This Biotech Stock Right Now
October 24, 2024
Via
The Motley Fool
Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
October 21, 2024
Via
Investor's Business Daily
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?
October 20, 2024
Via
Benzinga
Wave Life Sciences Rockets 70% on Historic RNA Editing Success
October 18, 2024
Via
MarketBeat
This Cisco Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 16, 2024
Via
Benzinga
Wave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In Humans
October 16, 2024
Via
Benzinga
Wave Life Sciences Just Edited RNA — And Shares Hit The Stratosphere
October 16, 2024
Via
Investor's Business Daily
United Airlines Posts Upbeat Earnings, Joins Morgan Stanley, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday
October 16, 2024
Via
Benzinga
Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
October 16, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024
October 16, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
October 03, 2024
Via
The Motley Fool
Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 01, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
September 30, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
September 25, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
General Motors To $42? Here Are 10 Top Analyst Forecasts For Wednesday
September 25, 2024
Via
Benzinga
Stitch Fix Reports Weak Earnings, Joins KB Home And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
September 25, 2024
Via
Benzinga
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
September 24, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Crude Oil Gains Over 1%; BioVie Shares Plunge
September 24, 2024
Via
Benzinga
Exposures
Fossil Fuels
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.